Platelet Leukocyte Interactions II in-Vivo Correction of Chediak-Higashi Leukocyte Function with Serotonin or Normal Platelets

  • S. S. Kaplan
  • R. E. Basford
  • S. S. Boggs
  • U. E. Zdziarski
  • R. B. JohnstonJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 141)


The formed elements of the peripheral blood often are characterized according to their separate primary functions in homeostasis. While these elements perform independently of each other, there is increasing evidence documenting an essential interaction between these formed elements. Some of these interactions, for example, have been shown to involve lymphocyte subtypes or lymphocytes and macrophages in cellular and humoral immunity1, and more recently, the relationship of neutrophilic metabolic activation to the platelet release reaction has been demonstrated2–7. We recently have presented evidence for the reversed interaction between neutrophils and platelets where a component of platelet dense bodies affects neutrophil function8. In these studies, platelet-leukocyte interactions were evaluated in-vitro, using the beige mouse, an animal model of the Chediak-Higashi (CH) syndrome, where both platelet and leukocyte function are defective. These studies demonstrated that normal platelets, or serotonin, a constituent of normal platelet-dense bodies which is absent in CH platelets, corrects the abnormal microbicidal activity of CH peripheral blood leukocytes. The present study further tests the hypothesis that platelet serotonin acts as an effector of PMN function be evaluating the effect of intravenous administration of normal platelets or of serotonin on CH leukocyte microbicidal activity, relating our findings to resulting platelet and plasma serotonin levels. The fate of the injected serotonin also was determined, and it was demonstrated that large amounts of the metabolite 5 hydroxyindole acetic acid (5-HIAA) are formed. This substance, however, has no effect on leukocyte function. These studies confirmed our initial in-vitro observations and showed that CH leukocyte function may be corrected in-vivo by normal platelets or serotonin but not by serotonin breakdown products.


Post Injection Bacterial Killing Normal Platelet Leukocyte Function Platelet Serotonin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. F. A. P. Miller, Cellular interactions in immune responses, Seminars in Hematology 16: 283 (1979).PubMedGoogle Scholar
  2. 2.
    R. A. Clark, and S. J. Klebanoff, Neutrophil platelet interaction mediated by myeloperoxidase and hydrogen peroxide, J. Immunol. 124: 399 (1980).PubMedGoogle Scholar
  3. 3.
    R. A. Clark, and S. J. Klebanoff, Myeloperoxidase mediated platelet release reaction, J. Clin. Invest. 63: 177 (1979).PubMedCrossRefGoogle Scholar
  4. 4.
    P. H. Levine, R. S. Weinger, J. Simon, K. L. Scoon, and N. I. Krinski, Leukocyte platelet interactions - release of hydrogen peroxide by granulocyte as a modulator of platelet reactions, J. Clin. Invest. 57: 955 (1976).PubMedCrossRefGoogle Scholar
  5. 5.
    R. Rodoren, J. N. Lindon, and P. H. Levine, Physiology and ultrastrucute of the blood platelet following exposure to hydrogen peroxide, Br. J. Hematol. 33: 19 (1976).CrossRefGoogle Scholar
  6. 6.
    H. Holmsen, and L. Robkin, Hydrogen peroxide lowers ATP levels in platelets without altering adequate energy change and platelet function, J. Biol. Chem. 252: 1752 (1977).PubMedGoogle Scholar
  7. 7.
    R. I. Handin, R. Karabin, and G. J. Boxer, Enhancement of platelet function by superoxide anion, J. Clin. Invest. 59: 959 (1977).PubMedCrossRefGoogle Scholar
  8. 8.
    S. S. Kaplan, S. S. Boggs, M. A. Nardi, R. E. Basford, and J. M. Holland, Leukocyte platelet interactions in a murine model of the Chediak-Higashi syndrome, Blood 52: 719 (1978).PubMedGoogle Scholar
  9. 9.
    S. S. Kaplan, and R. E. Basford, Effect of vitamin B12 and folic acid deficiencies on neutrophil function, Blood 47: 801, 1976.PubMedGoogle Scholar
  10. 10.
    G. Curzon, and A. R. Green, Rapid method for the determination of 5 hydroxy-tryptamine and 5 hydroxy-indole acetic acid in small regions of rat brain. Br. J. Pharmacol. 39: 653 (1970).PubMedCrossRefGoogle Scholar
  11. 11.
    G. Bartholini, A. Pletscher, and H. Broderer, Formation of hydroxy-tryptophol from endogenous 5 hydroxy-tryptamine by isolated blood platelets, Nature 203: 1201 (1964).CrossRefGoogle Scholar
  12. 12.
    J. M. Holland, Serotonin deficiency and prolonged bleeding in beige mice, Proc. Soc. Exp. Biol. Med. 151: 32 (1976).PubMedGoogle Scholar
  13. 13.
    T. G. Bell, K. A. Myers, D. J. Prieur, A. S. Fauce, S. M. Wolff, and G. A. Padgett, Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome, cattle and human platelets, Blood 48: 175 (1976).PubMedGoogle Scholar
  14. 14.
    S. N. Wolff, D. C. Dale, R. A. Clark, R. K. Root, and H. R. Kimball, The Chediak-Higashi syndrome: studies of host defenses, Ann. Int. Med. 76: 293 (1972).PubMedGoogle Scholar
  15. 15.
    R. K. Root, A. S. Rosenthal, and D. J. Balestra, Abnormal bactericidal metabolic and lysosomal functiòn of ChediakHigashi syndrome leukocytes, J. Clin. Invest. 51: 649 (1972).PubMedCrossRefGoogle Scholar
  16. 16.
    R. A. Kyle, Natural history of chronic idiopathic neutropenia, N. E. J. M. 302: 908 (1980).CrossRefGoogle Scholar
  17. 17.
    S. Udenfriend, E. Titus, H. Weissback, and R. E. Peterson, Biogenesis and metabolism of 5 hydroxy-indole compounds, J. Biol. Chem. 219: 335 (1956).PubMedGoogle Scholar
  18. 18.
    R. M. Hardesty, and R. S. Stacey, 5 hydroxy-tryptamine in normal platelets, J. Physiol. 130: 711 (1955).Google Scholar
  19. 19.
    J. I. Gallin, J. S. Bayak, E. Patten, and S. M. Wolff, Granulocyte function in the Chediak-Higashi syndrome of mice, Blood 403: 201 (1974).Google Scholar
  20. 20.
    R. Clark, and H. Kimball, Defective granulocyte chemotaxis in the Chediak-Higashi syndrome, J. Clin. Invest. 50: 2645 (1971).PubMedCrossRefGoogle Scholar
  21. 21.
    J. M. Oliver, Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome, Am. J. Path. 85: 395 (1976).PubMedGoogle Scholar
  22. 22.
    R. B. Zurier, G. Weissman, S. Hoff stein, S. Kammerman, and H. H. Tai, Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP & cGMP autonomic agonists and agents which affect microtubule function, J Clin. Invest. 53: 297 (1974).PubMedCrossRefGoogle Scholar
  23. 23.
    L. A. Boxer, D. F. Albertini, R. L. Baehner, and J. M. Oliver, Impaired microtubule assembly and polymorphonuclear leukocyte function in the Chediak-Higashi syndrome correctable by ascorbic acid, Br. J. Hemat. 43: 207, 1979.CrossRefGoogle Scholar
  24. 24.
    J. A. Sandler, R. E. Clyman, V. C. Mangamillo, and M. Vaughan, The effect of serotonin (5 hydroxy-tryptamine) and derivatives on guanosine 3’5’ monophosphate in human monocytes, J. Clin. Invest. 55: 431 (1975).PubMedCrossRefGoogle Scholar
  25. 25.
    J. A. Sandler, J. I. Gallin, and M. Vaughan, Effects of serotonin carbonylcholine and ascorbic acid on leukocyte GMP and chemotaxis, J. Cell. Biol. 67: 480 (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • S. S. Kaplan
    • 1
  • R. E. Basford
    • 1
  • S. S. Boggs
    • 1
  • U. E. Zdziarski
    • 1
  • R. B. JohnstonJr.
  1. 1.Departments of Pathology, Biochemistry, Radiation BiologyUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations